{
  "table_name": "quant_phosphoproteome_AML_ex_vivo_drug_response_combination_treatment_pdc_current",
  "table_fullname": "isb-cgc-bq.CPTAC.quant_phosphoproteome_AML_ex_vivo_drug_response_combination_treatment_pdc_current",
  "column_names": [
    "Fall-ID",
    "Proben-ID",
    "Aliquot-ID",
    "Aliquot-Einreicher-ID",
    "Aliquot-Lauf-Metadaten-ID",
    "Studienname",
    "Proteinabundanz-Log2-Verhältnis",
    "RefSeq-ID",
    "Phosphorylierungsstellen"
  ],
  "column_types": [
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "FLOAT64",
    "STRING",
    "STRING"
  ],
  "nested_column_names": [
    "Fall-ID",
    "Probe-ID",
    "Aliquot-ID",
    "Aliquot-Einreicher-ID",
    "Aliquot-Laufmetadaten-ID",
    "Studienname",
    "Proteinabundanz-Log2-Verhältnis",
    "RefSeq-ID",
    "Phosphorylierungsstellen"
  ],
  "nested_column_types": [
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "FLOAT64",
    "STRING",
    "STRING"
  ],
  "description": [
    "Eindeutige Kennung, die mit einem bestimmten Patienten verbunden ist (z. B. 24cb0fcb-63d6-11e8-bcf1-0a2705229b82)",
    "Einzigartige PDC-Identifikator für diese Probe (z. B. e8d83eb9-693a-11ea-b1fd-0aad30af8a83)",
    "Einzigartige PDC-Identifikator für dieses Aliquot (z. B. e8db124a-693a-11ea-b1fd-0aad30af8a83)",
    "Aliquot-Einreicher-ID, die vom Programm zugewiesen wird (z. B. T14)",
    "Eindeutige Identifikation des Aliquots anhand seiner Verwendung im Experiment (basierend auf dem Markierungsreagenz und/oder dem biologischen Replikat)",
    "Name der Studie (z. B. Pediatric Brain Cancer Pilot Study - Phosphoproteome)",
    "Durchschnittliches Log-Verhältnis des Proben-Reporter-Ions zur gemeinsamen Referenz der Peptidionen, die dem Gen in Messungen aus einer bestimmten biologischen Probe zugeordnet sind",
    "Einzigartige Kennung, die einer Sequenz in der NCBI RefSeq-Datenbank zugewiesen wird",
    "Einbuchstabencodes und Proteinsequenzpositionen der phosphorylierten Aminosäuren (z. B. t304s310, t59)"
  ],
  "sample_rows": [
    {
      "Fall-ID": "e4796a23-6e79-4159-8547-d7fbe13098c9",
      "Probe-ID": "dddc3c0f-af7c-453b-9929-fe6896297df1",
      "Aliquot-ID": "cc445b9a-5a06-48cc-854e-7a7611bf7b22",
      "Aliquot-Einreicher-ID": "15-00756-1",
      "Aliquot-Laufmetadaten-ID": "0b52440e-7094-4574-926d-b2720e6abc40",
      "Studienname": "AML Ex Vivo Drug Response - Combination Treatment - Phosphoproteome",
      "Proteinabundanz-Log2-Verhältnis": -1.0824,
      "RefSeq-ID": "NP_000170.1",
      "Phosphorylierungsstellen": "s252s261"
    },
    {
      "Fall-ID": "e4796a23-6e79-4159-8547-d7fbe13098c9",
      "Probe-ID": "dddc3c0f-af7c-453b-9929-fe6896297df1",
      "Aliquot-ID": "cc445b9a-5a06-48cc-854e-7a7611bf7b22",
      "Aliquot-Einreicher-ID": "15-00756-1",
      "Aliquot-Laufmetadaten-ID": "0b52440e-7094-4574-926d-b2720e6abc40",
      "Studienname": "AML Ex Vivo Drug Response - Combination Treatment - Phosphoproteome",
      "Proteinabundanz-Log2-Verhältnis": -1.9697,
      "RefSeq-ID": "NP_000876.3",
      "Phosphorylierungsstellen": "s1021"
    },
    {
      "Fall-ID": "e4796a23-6e79-4159-8547-d7fbe13098c9",
      "Probe-ID": "dddc3c0f-af7c-453b-9929-fe6896297df1",
      "Aliquot-ID": "cc445b9a-5a06-48cc-854e-7a7611bf7b22",
      "Aliquot-Einreicher-ID": "15-00756-1",
      "Aliquot-Laufmetadaten-ID": "0b52440e-7094-4574-926d-b2720e6abc40",
      "Studienname": "AML Ex Vivo Drug Response - Combination Treatment - Phosphoproteome",
      "Proteinabundanz-Log2-Verhältnis": 1.322,
      "RefSeq-ID": "NP_000876.3",
      "Phosphorylierungsstellen": "s424"
    },
    {
      "Fall-ID": "e4796a23-6e79-4159-8547-d7fbe13098c9",
      "Probe-ID": "dddc3c0f-af7c-453b-9929-fe6896297df1",
      "Aliquot-ID": "cc445b9a-5a06-48cc-854e-7a7611bf7b22",
      "Aliquot-Einreicher-ID": "15-00756-1",
      "Aliquot-Laufmetadaten-ID": "0b52440e-7094-4574-926d-b2720e6abc40",
      "Studienname": "AML Ex Vivo Drug Response - Combination Treatment - Phosphoproteome",
      "Proteinabundanz-Log2-Verhältnis": -1.7199,
      "RefSeq-ID": "NP_000959.2",
      "Phosphorylierungsstellen": "s365"
    },
    {
      "Fall-ID": "e4796a23-6e79-4159-8547-d7fbe13098c9",
      "Probe-ID": "dddc3c0f-af7c-453b-9929-fe6896297df1",
      "Aliquot-ID": "cc445b9a-5a06-48cc-854e-7a7611bf7b22",
      "Aliquot-Einreicher-ID": "15-00756-1",
      "Aliquot-Laufmetadaten-ID": "0b52440e-7094-4574-926d-b2720e6abc40",
      "Studienname": "AML Ex Vivo Drug Response - Combination Treatment - Phosphoproteome",
      "Proteinabundanz-Log2-Verhältnis": -0.387,
      "RefSeq-ID": "NP_001001998.1",
      "Phosphorylierungsstellen": "s13"
    }
  ]
}